Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo controlled, phase 2 trial

S. E. Gitelman, P. A. Gottlieb, M. R. Rigby, E. I. Felner, S. M. Willi, L. K. Fisher, A. Moran, M. Gottschalk, W. V. Moore, A. Pinckney, L. Keyes-Elstein, S. Aggarwal, D. Phippard, P. H. Sayre, L. Ding, J. A. Bluestone, M. R. Ehlers

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)S89
JournalDiabetes Technology and Therapeutics
Issue numberSUPPL. 1
StatePublished - 2014

Cite this